Atlas Trials

Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson's Disease

Clinical trial NCT04643327 · RECRUITING

Trial details

NCT number
NCT04643327
Sponsor
The University of Queensland
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson DiseaseMild Cognitive ImpairmentMemory Impairment
Start date
2021-02-09
Primary completion
2025-01-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.